Global Osteoarthritis Pain Drugs Sales Market Report 2021

    • ID: AR3033545
    • 01 April, 2021
    • Other
    • Region: Global
    • 147 Pages
    • QYResearch

    1 Osteoarthritis Pain Drugs Market Overview

    • 1.1 Osteoarthritis Pain Drugs Product Scope
    • 1.2 Osteoarthritis Pain Drugs Segment by Type
      • 1.2.1 Global Osteoarthritis Pain Drugs Sales by Type (2016 & 2021 & 2027)
      • 1.2.2 Oral
      • 1.2.3 Injection
      • 1.2.4 External
    • 1.3 Osteoarthritis Pain Drugs Segment by Application
      • 1.3.1 Global Osteoarthritis Pain Drugs Sales Comparison by Application (2016 & 2021 & 2027)
      • 1.3.2 Medical Care
      • 1.3.3 Personal Care
    • 1.4 Osteoarthritis Pain Drugs Market Estimates and Forecasts (2016-2027)
      • 1.4.1 Global Osteoarthritis Pain Drugs Market Size in Value Growth Rate (2016-2027)
      • 1.4.2 Global Osteoarthritis Pain Drugs Market Size in Volume Growth Rate (2016-2027)
      • 1.4.3 Global Osteoarthritis Pain Drugs Price Trends (2016-2027)

    2 Osteoarthritis Pain Drugs Estimates and Forecasts by Region

    • 2.1 Global Osteoarthritis Pain Drugs Market Size by Region: 2016 VS 2021 VS 2027
    • 2.2 Global Osteoarthritis Pain Drugs Retrospective Market Scenario by Region (2016-2021)
      • 2.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
      • 2.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
    • 2.3 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Region (2022-2027)
      • 2.3.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts by Region (2022-2027)
      • 2.3.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2022-2027)
    • 2.4 Geographic Market Analysis: Market Facts & Figures
      • 2.4.1 North America Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
      • 2.4.2 Europe Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
      • 2.4.3 China Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
      • 2.4.4 Japan Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
      • 2.4.5 Southeast Asia Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
      • 2.4.6 India Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)

    3 Global Osteoarthritis Pain Drugs Competition Landscape by Players

    • 3.1 Global Top Osteoarthritis Pain Drugs Players by Sales (2016-2021)
    • 3.2 Global Top Osteoarthritis Pain Drugs Players by Revenue (2016-2021)
    • 3.3 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2020)
    • 3.4 Global Osteoarthritis Pain Drugs Average Price by Company (2016-2021)
    • 3.5 Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites, Area Served, Product Type
    • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Global Osteoarthritis Pain Drugs Market Size by Type

    • 4.1 Global Osteoarthritis Pain Drugs Historic Market Review by Type (2016-2021)
      • 4.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
      • 4.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)
      • 4.1.3 Global Osteoarthritis Pain Drugs Price by Type (2016-2021)
    • 4.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Type (2022-2027)
      • 4.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2022-2027)
      • 4.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2022-2027)
      • 4.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Type (2022-2027)

    5 Global Osteoarthritis Pain Drugs Market Size by Application

    • 5.1 Global Osteoarthritis Pain Drugs Historic Market Review by Application (2016-2021)
      • 5.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
      • 5.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2021)
      • 5.1.3 Global Osteoarthritis Pain Drugs Price by Application (2016-2021)
    • 5.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Application (2022-2027)
      • 5.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2022-2027)
      • 5.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2022-2027)
      • 5.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Application (2022-2027)

    6 North America Osteoarthritis Pain Drugs Market Facts & Figures

    • 6.1 North America Osteoarthritis Pain Drugs Sales by Company
      • 6.1.1 North America Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 6.1.2 North America Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 6.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 6.2.1 North America Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 6.2.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 6.3 North America Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 6.3.1 North America Osteoarthritis Pain Drugs Sales Breakdown by Application (2016-2021)
      • 6.3.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Application (2022-2027)

    7 Europe Osteoarthritis Pain Drugs Market Facts & Figures

    • 7.1 Europe Osteoarthritis Pain Drugs Sales by Company
      • 7.1.1 Europe Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 7.2 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 7.2.1 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 7.2.2 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 7.3 Europe Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
      • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

    8 China Osteoarthritis Pain Drugs Market Facts & Figures

    • 8.1 China Osteoarthritis Pain Drugs Sales by Company
      • 8.1.1 China Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 8.1.2 China Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 8.2 China Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 8.2.1 China Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 8.2.2 China Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 8.3 China Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 8.3.1 China 311 Sales Breakdown by Application (2016-2021)
      • 8.3.2 China 311 Sales Breakdown by Application (2022-2027)

    9 Japan Osteoarthritis Pain Drugs Market Facts & Figures

    • 9.1 Japan Osteoarthritis Pain Drugs Sales by Company
      • 9.1.1 Japan Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 9.1.2 Japan Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 9.2 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 9.2.1 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 9.2.2 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 9.3 Japan Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
      • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

    10 Southeast Asia Osteoarthritis Pain Drugs Market Facts & Figures

    • 10.1 Southeast Asia Osteoarthritis Pain Drugs Sales by Company
      • 10.1.1 Southeast Asia Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 10.1.2 Southeast Asia Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 10.2 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 10.2.1 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 10.2.2 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 10.3 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 10.3.1 Southeast Asia M Dose Sales Breakdown by Application (2016-2021)
      • 10.3.2 Southeast Asia M Dose Sales Breakdown by Application (2022-2027)

    11 India Osteoarthritis Pain Drugs Market Facts & Figures

    • 11.1 India Osteoarthritis Pain Drugs Sales by Company
      • 11.1.1 India Osteoarthritis Pain Drugs Sales by Company (2016-2021)
      • 11.1.2 India Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
    • 11.2 India Osteoarthritis Pain Drugs Sales Breakdown by Type
      • 11.2.1 India Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
      • 11.2.2 India Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
    • 11.3 India Osteoarthritis Pain Drugs Sales Breakdown by Application
      • 11.3.1 India Osteoarthritis Pain Drugs Sales Breakdown by Application (2016-2021)
      • 11.3.2 India Osteoarthritis Pain Drugs Sales Breakdown by Application (2022-2027)

    12 Company Profiles and Key Figures in Osteoarthritis Pain Drugs Business

    • 12.1 Sino Biopharmaceutical
      • 12.1.1 Sino Biopharmaceutical Corporation Information
      • 12.1.2 Sino Biopharmaceutical Business Overview
      • 12.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Products Offered
      • 12.1.5 Sino Biopharmaceutical Recent Development
    • 12.2 Chugai Pharmaceutical
      • 12.2.1 Chugai Pharmaceutical Corporation Information
      • 12.2.2 Chugai Pharmaceutical Business Overview
      • 12.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.2.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Products Offered
      • 12.2.5 Chugai Pharmaceutical Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Corporation Information
      • 12.3.2 Pfizer Business Overview
      • 12.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.3.4 Pfizer Osteoarthritis Pain Drugs Products Offered
      • 12.3.5 Pfizer Recent Development
    • 12.4 Mikasa Seiyaku
      • 12.4.1 Mikasa Seiyaku Corporation Information
      • 12.4.2 Mikasa Seiyaku Business Overview
      • 12.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.4.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Products Offered
      • 12.4.5 Mikasa Seiyaku Recent Development
    • 12.5 Bayer
      • 12.5.1 Bayer Corporation Information
      • 12.5.2 Bayer Business Overview
      • 12.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.5.4 Bayer Osteoarthritis Pain Drugs Products Offered
      • 12.5.5 Bayer Recent Development
    • 12.6 Haohai Biological
      • 12.6.1 Haohai Biological Corporation Information
      • 12.6.2 Haohai Biological Business Overview
      • 12.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.6.4 Haohai Biological Osteoarthritis Pain Drugs Products Offered
      • 12.6.5 Haohai Biological Recent Development
    • 12.7 SK Chemicals
      • 12.7.1 SK Chemicals Corporation Information
      • 12.7.2 SK Chemicals Business Overview
      • 12.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.7.4 SK Chemicals Osteoarthritis Pain Drugs Products Offered
      • 12.7.5 SK Chemicals Recent Development
    • 12.8 Taisho Pharmaceutical
      • 12.8.1 Taisho Pharmaceutical Corporation Information
      • 12.8.2 Taisho Pharmaceutical Business Overview
      • 12.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.8.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Products Offered
      • 12.8.5 Taisho Pharmaceutical Recent Development
    • 12.9 Zhejiang Chengyi Pharmaceutical
      • 12.9.1 Zhejiang Chengyi Pharmaceutical Corporation Information
      • 12.9.2 Zhejiang Chengyi Pharmaceutical Business Overview
      • 12.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.9.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Products Offered
      • 12.9.5 Zhejiang Chengyi Pharmaceutical Recent Development
    • 12.10 Freda
      • 12.10.1 Freda Corporation Information
      • 12.10.2 Freda Business Overview
      • 12.10.3 Freda Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.10.4 Freda Osteoarthritis Pain Drugs Products Offered
      • 12.10.5 Freda Recent Development
    • 12.11 Bright Future
      • 12.11.1 Bright Future Corporation Information
      • 12.11.2 Bright Future Business Overview
      • 12.11.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.11.4 Bright Future Osteoarthritis Pain Drugs Products Offered
      • 12.11.5 Bright Future Recent Development
    • 12.12 Jingfeng Pharmaceutical
      • 12.12.1 Jingfeng Pharmaceutical Corporation Information
      • 12.12.2 Jingfeng Pharmaceutical Business Overview
      • 12.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.12.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Products Offered
      • 12.12.5 Jingfeng Pharmaceutical Recent Development
    • 12.13 Seikagaku Corporation
      • 12.13.1 Seikagaku Corporation Corporation Information
      • 12.13.2 Seikagaku Corporation Business Overview
      • 12.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.13.4 Seikagaku Corporation Osteoarthritis Pain Drugs Products Offered
      • 12.13.5 Seikagaku Corporation Recent Development
    • 12.14 GSK
      • 12.14.1 GSK Corporation Information
      • 12.14.2 GSK Business Overview
      • 12.14.3 GSK Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.14.4 GSK Osteoarthritis Pain Drugs Products Offered
      • 12.14.5 GSK Recent Development
    • 12.15 Sanofi
      • 12.15.1 Sanofi Corporation Information
      • 12.15.2 Sanofi Business Overview
      • 12.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.15.4 Sanofi Osteoarthritis Pain Drugs Products Offered
      • 12.15.5 Sanofi Recent Development
    • 12.16 Crystal Genomics
      • 12.16.1 Crystal Genomics Corporation Information
      • 12.16.2 Crystal Genomics Business Overview
      • 12.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.16.4 Crystal Genomics Osteoarthritis Pain Drugs Products Offered
      • 12.16.5 Crystal Genomics Recent Development
    • 12.17 Johnson & Johnson
      • 12.17.1 Johnson & Johnson Corporation Information
      • 12.17.2 Johnson & Johnson Business Overview
      • 12.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.17.4 Johnson & Johnson Osteoarthritis Pain Drugs Products Offered
      • 12.17.5 Johnson & Johnson Recent Development
    • 12.18 GlaxoSmithKline
      • 12.18.1 GlaxoSmithKline Corporation Information
      • 12.18.2 GlaxoSmithKline Business Overview
      • 12.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Products Offered
      • 12.18.5 GlaxoSmithKline Recent Development
    • 12.19 Mylan
      • 12.19.1 Mylan Corporation Information
      • 12.19.2 Mylan Business Overview
      • 12.19.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.19.4 Mylan Osteoarthritis Pain Drugs Products Offered
      • 12.19.5 Mylan Recent Development
    • 12.20 Lilly
      • 12.20.1 Lilly Corporation Information
      • 12.20.2 Lilly Business Overview
      • 12.20.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.20.4 Lilly Osteoarthritis Pain Drugs Products Offered
      • 12.20.5 Lilly Recent Development
    • 12.21 Abbott Laboratories
      • 12.21.1 Abbott Laboratories Corporation Information
      • 12.21.2 Abbott Laboratories Business Overview
      • 12.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.21.4 Abbott Laboratories Osteoarthritis Pain Drugs Products Offered
      • 12.21.5 Abbott Laboratories Recent Development
    • 12.22 Almatica Pharma
      • 12.22.1 Almatica Pharma Corporation Information
      • 12.22.2 Almatica Pharma Business Overview
      • 12.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.22.4 Almatica Pharma Osteoarthritis Pain Drugs Products Offered
      • 12.22.5 Almatica Pharma Recent Development
    • 12.23 TEVA
      • 12.23.1 TEVA Corporation Information
      • 12.23.2 TEVA Business Overview
      • 12.23.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.23.4 TEVA Osteoarthritis Pain Drugs Products Offered
      • 12.23.5 TEVA Recent Development
    • 12.24 Iroko Pharmaceuticals
      • 12.24.1 Iroko Pharmaceuticals Corporation Information
      • 12.24.2 Iroko Pharmaceuticals Business Overview
      • 12.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
      • 12.24.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Products Offered
      • 12.24.5 Iroko Pharmaceuticals Recent Development

    13 Osteoarthritis Pain Drugs Manufacturing Cost Analysis

    • 13.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
    • 13.4 Osteoarthritis Pain Drugs Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Osteoarthritis Pain Drugs Distributors List
    • 14.3 Osteoarthritis Pain Drugs Customers

    15 Market Dynamics

    • 15.1 Osteoarthritis Pain Drugs Market Trends
    • 15.2 Osteoarthritis Pain Drugs Drivers
    • 15.3 Osteoarthritis Pain Drugs Market Challenges
    • 15.4 Osteoarthritis Pain Drugs Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Osteoarthritis Pain Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      Oral
      Injection
      External

      Segment by Application
      Medical Care
      Personal Care

      The Osteoarthritis Pain Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Osteoarthritis Pain Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Sino Biopharmaceutical
      Chugai Pharmaceutical
      Pfizer
      Mikasa Seiyaku
      Bayer
      Haohai Biological
      SK Chemicals
      Taisho Pharmaceutical
      Zhejiang Chengyi Pharmaceutical
      Freda
      Bright Future
      Jingfeng Pharmaceutical
      Seikagaku Corporation
      GSK
      Sanofi
      Crystal Genomics
      Johnson & Johnson
      GlaxoSmithKline
      Mylan
      Lilly
      Abbott Laboratories
      Almatica Pharma
      TEVA
      Iroko Pharmaceuticals



      Summary:
      Osteoarthritis Pain Drugs Market Research Report is about Osteoarthritis Pain Drugs Industry study. Get complete Osteoarthritis Pain Drugs market research report published after Market Study, Industrial Analysis with Trends & Statistics. Osteoarthritis Pain Drugs Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $4,000.00

      Global Inkjet Printer Head Sales Market Report 2021

      • 145 Pages
      • Region: Global
      $4,000.00
      $4,000.00
      $4,000.00
      $4,000.00